Clinical Trial Update: Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 long-term safety data for alogliptin in combination with a sulfonylurea or metformin in Japanese patients with type 2 diabetes were completed, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)
• Sulfonylurea (sulfonylurea)
• metformin (metformin)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-08-16